Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05337553 |
|---|---|
| Brief Title: | A Study to Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Participants With Spinal Muscular Atrophy (RESILIENT) |
| First Submitted : | April 14, 2022 |
| First Submitted that Met QC Criteria : | April 14, 2022 |
| First Posted : | April 20, 2022 |
| Last Update Submitted that Met QC Criteria : | November 6, 2023 |
| Last Update Posted : | November 7, 2023 |